Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Le Bris

Showing results (361-370 of 387) with videos related to

Pageof 39
Sort By:
Haematologica|December 23, 2017
Emergence and evolution of <i>TP53</i> mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomideLaurence Lodé, Audrey Ménard, Laurent Flet, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 25, 2019
Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patientsAnne Jouinot, Guillaume Ulmann, Clara Vazeille, et al.
The New Phytologist|June 16, 2017
Expression atlas and comparative coexpression network analyses reveal important genes involved in the formation of lignified cell wall in Brachypodium distachyonRichard Sibout, Sebastian Proost, Bjoern Oest Hansen, et al.
Scientific Reports|September 22, 2020
Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograftMaxime Jullien, Thierry Guillaume, Pierre Peterlin, et al.
Blood|December 14, 2023
A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimeticsRomane Durand, Géraldine Descamps, Céline Bellanger, et al.
Hematological Oncology|May 31, 2020
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA groupYannick Le Bris, Florence Magrangeas, Anne Moreau, et al.
American Journal of Hematology|January 2, 2024
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamideMaxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, et al.
International Journal of Laboratory Hematology|September 14, 2024
Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome ScreeningCédric De Almeida Braga, Maxence Bauvais, Pierre Sujobert, et al.
Cancer Medicine|December 28, 2020
A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
Cytokine|April 30, 2019
FLT3 ligand plasma levels have no impact on outcomes after allotransplant in acute leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
Pageof 39

Showing results (361-370 of 387) with videos related to

Sort By:
Pageof 39
Haematologica|December 23, 2017
Emergence and evolution of <i>TP53</i> mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomideLaurence Lodé, Audrey Ménard, Laurent Flet, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 25, 2019
Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patientsAnne Jouinot, Guillaume Ulmann, Clara Vazeille, et al.
The New Phytologist|June 16, 2017
Expression atlas and comparative coexpression network analyses reveal important genes involved in the formation of lignified cell wall in Brachypodium distachyonRichard Sibout, Sebastian Proost, Bjoern Oest Hansen, et al.
Scientific Reports|September 22, 2020
Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograftMaxime Jullien, Thierry Guillaume, Pierre Peterlin, et al.
Blood|December 14, 2023
A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimeticsRomane Durand, Géraldine Descamps, Céline Bellanger, et al.
Hematological Oncology|May 31, 2020
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA groupYannick Le Bris, Florence Magrangeas, Anne Moreau, et al.
American Journal of Hematology|January 2, 2024
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamideMaxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, et al.
International Journal of Laboratory Hematology|September 14, 2024
Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome ScreeningCédric De Almeida Braga, Maxence Bauvais, Pierre Sujobert, et al.
Cancer Medicine|December 28, 2020
A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
Cytokine|April 30, 2019
FLT3 ligand plasma levels have no impact on outcomes after allotransplant in acute leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
Pageof 39